Apollo Hospitals Q2 FY27 Results: Revenue, Occupancy and Margins

Apollo Hospitals Prepares to Announce September-Quarter Financial Results

Apollo Hospitals Enterprise Limited is scheduled to announce its financial results for the second quarter of FY2026–27 on Wednesday, November 4, 2026, with investors closely monitoring hospital occupancy, revenue growth, operating margins and the financial impact of its expansion programme.

The company's board will consider and approve the unaudited standalone and consolidated financial results for the quarter and six months ended September 30, 2026.

An earnings conference call with analysts and institutional investors is scheduled for November 5 at 3:00 PM IST.

The announcement follows a strong June quarter, during which Apollo Hospitals reported consolidated revenue of approximately ₹7,043 crore, representing year-on-year growth of 21%.

Consolidated earnings before interest, tax, depreciation and amortisation (EBITDA) increased 28% to approximately ₹1,092 crore, while adjusted profit after tax rose 34% to ₹581 crore.

Hospital occupancy improved to 70% from 65% a year earlier, supported by demand for complex medical procedures and specialised healthcare services.

The September-quarter results will indicate whether this momentum continued during the second quarter.

Investors will also assess progress towards profitability in the company's digital healthcare operations and the impact of investments in new hospital capacity.

Apollo Hospitals Q2 FY27 Results: Key Details

The results will provide an important update on the company's hospital operations, pharmacy business and digital healthcare activities.

Strong Q1 FY27 Performance Establishes Earnings Benchmark

Apollo Hospitals entered the September quarter following strong financial performance in the April–June period.

Revenue from operations increased approximately 21% year on year to ₹7,043 crore.

EBITDA rose 28% to ₹1,092 crore, indicating that operating earnings grew faster than revenue.

Adjusted profit after tax increased 34% to ₹581 crore.

The improvement reflected stronger demand for healthcare services and continued growth in the company's pharmacy-related operations.

The hospital business remained an important contributor.

Healthcare services revenue increased approximately 22% year on year.

The company also benefited from increased demand for specialised medical procedures.

However, the September-quarter results will provide a clearer indication of whether the growth trend remains sustainable.

Apollo Hospitals Q1 FY27 Financial Performance

The figures provide a reference point for assessing the September-quarter performance.

Q2 FY26 Results Provide Year-on-Year Comparison

Investors will also compare the upcoming results with the September quarter of the previous financial year.

Apollo Hospitals reported consolidated revenue of approximately ₹6,304 crore in Q2 FY26.

EBITDA stood at approximately ₹941 crore, translating into an operating margin of around 14.9%.

Consolidated profit after tax was approximately ₹477 crore.

These figures establish the base for evaluating year-on-year growth.

Revenue expansion above the previous year's level would indicate continued business growth.

However, profitability will depend on operating costs, hospital utilisation and the performance of newer facilities.

Investors will also examine whether margins improve compared with the previous-year period.

Previous September-Quarter Financial Performance

The upcoming Q2 FY27 results will determine the extent of improvement relative to these figures.

Hospital Occupancy Remains a Critical Operating Indicator

Hospital occupancy is among the most important indicators of operational performance for healthcare providers.

It measures the proportion of available hospital beds occupied by patients during a reporting period.

Higher occupancy can support revenue growth because hospitals are able to utilise their infrastructure more efficiently.

However, occupancy must be assessed alongside patient mix, treatment complexity and pricing.

A hospital treating a greater proportion of patients requiring specialised procedures may generate higher revenue even without a significant increase in occupancy.

Apollo Hospitals reported occupancy of 70% in Q1 FY27, compared with 65% in the corresponding quarter of the previous year.

The five-percentage-point improvement reflected stronger demand and better utilisation.

Investors will examine whether occupancy remained at similar levels during the September quarter.

Hospital Occupancy: Why It Matters

Occupancy is important, but it does not independently determine hospital profitability.

Demand for Complex Medical Procedures Supports Growth

Apollo Hospitals has benefited from demand for complex medical treatments.

These include cardiology, oncology, neurology, gastroenterology and orthopaedic procedures.

Such services often require specialised medical teams, advanced equipment and longer treatment pathways.

Demand for these procedures can influence average revenue per occupied bed.

In the June quarter, high-acuity specialties recorded growth of approximately 24%.

These specialties accounted for around 62% of inpatient revenue.

The performance suggests that the company's revenue growth has been supported by treatment complexity as well as patient volumes.

Investors will monitor whether this trend continued in Q2 FY27.

However, the contribution of complex procedures may vary between hospitals and reporting periods.

Average Revenue per Occupied Bed Will Be Closely Watched

Average revenue per occupied bed, commonly known as ARPOB, is an important measure of hospital revenue productivity.

It indicates the revenue generated from occupied beds over a defined period.

ARPOB can be influenced by treatment complexity, patient mix, pricing and length of stay.

Higher ARPOB may support revenue growth.

However, the metric should be considered alongside occupancy and operating expenses.

For example, revenue per occupied bed may increase because a hospital treats more complex cases.

At the same time, these procedures may require additional staffing and medical equipment.

Investors will therefore assess whether changes in ARPOB translate into stronger profitability.

Hospital Revenue Growth Remains a Major Earnings Driver

Apollo Hospitals' healthcare services business reported revenue of approximately ₹3,567 crore in Q1 FY27.

This represented year-on-year growth of about 22%.

The performance reflected strong demand across the company's hospital network.

Revenue growth can result from several factors, including higher patient volumes, increased occupancy, specialised procedures and new facilities.

However, expansion also creates additional operating expenses.

The September-quarter results will help determine whether the company's existing hospitals continued to generate strong revenue.

Investors will also examine the contribution from recently opened facilities.

A distinction between mature hospitals and new hospitals is important because their profitability profiles can differ substantially.

EBITDA Margins Will Be Central to Investor Assessment

EBITDA margins indicate the proportion of revenue retained as operating earnings before interest, tax, depreciation and amortisation.

For hospital operators, margins are influenced by patient volumes, treatment mix, employee expenses and operating efficiency.

Apollo Hospitals reported consolidated EBITDA of approximately ₹1,092 crore in Q1 FY27.

This represented a margin of approximately 15.5%.

The figure was higher than the approximately 14.9% margin reported in Q2 FY26.

However, a direct comparison between these quarters does not establish the September-quarter trend.

Investors will assess whether Apollo Hospitals maintained or improved profitability during Q2 FY27.

The results will also reveal whether costs associated with new hospitals affected consolidated margins.

Apollo Hospitals EBITDA Margin Comparison

Apollo Hospitals reported EBITDA margins

Historical quarters; percentage of consolidated revenue

 

Q2 FY27 EBITDA margin remains to be confirmed in the scheduled results.

Hospital Expansion Creates Growth Opportunities and Costs

Apollo Hospitals is pursuing a substantial hospital capacity expansion programme.

The company plans to add more than 5,800 beds over approximately five years.

The expansion is intended to strengthen its presence in major metropolitan areas, urban clusters and smaller cities.

Additional capacity can support long-term revenue growth.

However, new hospitals typically require time to build patient volumes and reach mature profitability levels.

Initial expenses may include staffing, equipment, maintenance and administrative costs.

These costs can affect margins before occupancy improves.

Investors will therefore assess both the scale of expansion and the pace at which new facilities become profitable.

New Hospital Ramp-Up Costs Could Influence FY27 Profitability

Management has indicated that losses associated with the ramp-up of new hospitals could reach approximately ₹150 crore at the EBITDA level during FY27.

Facilities in Bengaluru and Gurugram are among those expected to contribute to the expansion programme.

These investments may temporarily reduce consolidated profitability.

However, they are intended to create additional revenue capacity over time.

The financial outcome will depend on patient demand, utilisation and operating efficiency.

Investors will monitor whether the company's actual expansion-related costs remain consistent with management's expectations.

They will also examine the progress of newly commissioned facilities.

Apollo HealthCo Remains an Important Business Segment

Apollo HealthCo combines pharmacy and digital healthcare activities.

The business has become an important component of Apollo Hospitals' consolidated operations.

In Q1 FY27, HealthCo reported revenue of approximately ₹2,977 crore.

The segment generated EBITDA of around ₹171 crore.

Growth in the pharmacy business contributed to overall performance.

However, the digital healthcare operations have required investment.

The September-quarter results will provide an update on the profitability of these activities.

Investors will examine whether revenue growth is accompanied by improved operating efficiency.

Apollo 24/7 Digital Business Approaches Breakeven Target

Apollo's digital healthcare business has been working towards operating breakeven.

The company previously indicated that the digital business was targeting breakeven around Q2 FY27.

Digital cash losses had narrowed to approximately ₹10 crore in Q1 FY27.

This represented progress towards improved financial performance.

However, reaching breakeven depends on revenue growth, customer acquisition costs and operating expenses.

The September-quarter results may clarify whether the business achieved its target.

Investors will also examine whether improvements are sustainable.

A single profitable quarter would not necessarily establish a long-term trend.

Pharmacy Business Provides Revenue Diversification

Apollo Hospitals operates a large pharmacy and healthcare distribution business.

Pharmacy operations provide revenue beyond hospital admissions.

This diversification can help reduce dependence on inpatient healthcare services.

However, pharmacy businesses generally have different margin characteristics from hospital operations.

Revenue growth in pharmacy distribution may not translate into the same profitability as specialised medical services.

Investors will therefore assess the performance of the pharmacy business separately.

The contribution from digital operations will also be important.

The combination of physical pharmacy distribution and digital services remains a significant part of the company's broader healthcare strategy.

Operating Costs Could Affect Quarterly Margins

Hospital profitability depends on several categories of expenditure.

Employee costs are particularly important because healthcare services require specialised medical professionals.

Other expenses include medical supplies, utilities, maintenance and technology infrastructure.

New hospital openings can increase operating costs before facilities reach optimal utilisation.

Inflation can also affect procurement expenses.

Apollo Hospitals has previously highlighted potential cost pressures associated with regional supply-chain conditions and inflation.

Investors will assess whether the company has been able to offset these pressures through higher revenue and operational efficiency.

Key Factors Influencing Hospital Profitability

The September-quarter results will show how these factors affected Apollo Hospitals' financial performance.

India's Healthcare Demand Supports Long-Term Expansion

India's private hospital industry has benefited from rising demand for specialised healthcare services.

Factors supporting demand include population growth, increasing healthcare awareness and a greater need for treatment of chronic diseases.

Private healthcare providers are expanding capacity to address these requirements.

However, demand differs across regions and medical specialties.

Hospital operators must consider local competition, affordability and the availability of medical professionals.

Expansion also requires significant capital expenditure.

For Apollo Hospitals, the challenge is to convert growing healthcare demand into sustainable profitability.

The September-quarter results will provide another measure of operational progress.

Healthcare Sector Competition Remains Important

Apollo Hospitals operates in a competitive healthcare market.

Other listed hospital operators include Max Healthcare, Fortis Healthcare and Global Health.

These companies compete for patients, medical professionals and expansion opportunities.

However, comparisons must account for differences in hospital networks, treatment mix and business structures.

Apollo Hospitals also has substantial pharmacy and digital healthcare operations.

These businesses influence consolidated revenue and margins.

Consequently, hospital-only comparisons may provide a more meaningful assessment of certain operating metrics.

Investors will evaluate Apollo's performance against both its historical results and broader industry trends.

Apollo Hospitals' Earnings Could Influence Healthcare Stock Sentiment

Apollo Hospitals is among India's prominent listed healthcare companies.

Its quarterly results can provide insight into demand for private hospital services.

Strong occupancy and revenue growth may support confidence in the sector.

However, weaker margins could raise concerns about operating expenses and expansion costs.

Investors may also compare Apollo's results with those of other hospital operators.

The financial performance of one company does not determine the outlook for the entire industry.

Nevertheless, Apollo's scale makes its results relevant to assessments of India's healthcare services market.

Key Financial and Operating Indicators to Monitor

These indicators will help investors evaluate the quality of earnings growth.

Risks Facing Apollo Hospitals

Despite strong recent performance, Apollo Hospitals faces several operating and financial risks.

New hospitals may take longer than expected to achieve optimal occupancy.

Employee and medical supply costs could increase.

Digital healthcare operations may require continued investment.

Competition may affect patient acquisition and pricing.

Regulatory developments can also influence healthcare providers.

In addition, hospital expansion requires substantial capital expenditure.

These risks do not necessarily imply weaker future performance.

However, they are relevant when assessing whether historical growth rates can be maintained.

Factors Supporting and Limiting Future Growth

The balance between these factors will influence the company's earnings trajectory.

Earnings Conference Call Scheduled for November 5

Apollo Hospitals has scheduled its earnings conference call for November 5, 2026, at 3:00 PM IST.

The call is expected to provide management commentary on the September-quarter results.

Analysts will likely focus on hospital occupancy, revenue growth and operating margins.

Expansion costs and new hospital performance may also be important discussion points.

Investors will seek updates on Apollo HealthCo and the digital business's breakeven objective.

Management's assessment of demand trends and capacity expansion could influence expectations for the remainder of FY27.

However, any forward-looking statements will remain subject to market and operating conditions.

Outlook for Apollo Hospitals in FY27

Apollo Hospitals enters the second half of FY27 with a substantial hospital expansion programme and growing demand for specialised healthcare services.

The company's June-quarter performance demonstrated strong revenue and earnings growth.

However, the September-quarter results will provide a more recent assessment of operational momentum.

Hospital occupancy and ARPOB will remain important measures of revenue productivity.

Operating margins will indicate whether higher revenue is translating into improved profitability.

Investors will also monitor whether expansion-related costs remain within expectations.

Progress towards digital healthcare breakeven could provide an additional positive development.

The company's longer-term performance will depend on balancing capacity expansion with financial discipline.

Conclusion

Apollo Hospitals Enterprise Limited is scheduled to announce its Q2 FY27 financial results on November 4, 2026, with an analyst and investor conference call planned for November 5.

The announcement follows a strong June quarter in which consolidated revenue increased 21% to approximately ₹7,043 crore, EBITDA rose 28% to ₹1,092 crore and adjusted profit after tax advanced 34% to ₹581 crore.

Hospital occupancy improved to 70%, supported by demand for specialised medical procedures.

Investors will now assess whether the company maintained this momentum during the September quarter.

Operating margins, revenue per occupied bed and the performance of newly opened hospitals will be important indicators.

Apollo HealthCo's financial performance and progress towards digital business breakeven will also attract attention.

The company's plan to add more than 5,800 beds over five years offers long-term growth potential but introduces expansion-related costs.

For shareholders, the central question is whether Apollo Hospitals can sustain strong healthcare demand while maintaining profitability during a period of significant capacity investment.